Global Biochips (Microarrays/Microfluidics) Market By Type (DNA Chip, Lab-on-a-chip, and Protein Chip), By Application (Academics Institutes, and Diagnostics Centers), By Region and Key Companies - Industry Segment Outlook, Market Assessment, Competition Scenario, Trends and Forecast 2020-2029
- 133958
- 12-Dec
- PDF/PPT/Word
-
Report Details
The report on Biochips (Microarrays/Microfluidics) Market offers in-depth analysis on market trends, drivers, restraints, opportunities etc. Along with qualitative information, this report include the quantitative analysis of various segments in terms of market share, growth, opportunity analysis, market value, etc. for the forecast years. The global biochips (microarrays/microfluidics) market is segmented on the basis of Type, Application and geography.
The global Biochips (Microarrays/Microfluidics) market was valued at US$ XX.X Mn in 2018 and is projected to increase significantly at a CAGR of x.x% from 2019 to 2028.
Biochips (Microarrays/Microfluidics) Market Scope:
By type, the market is segmented into DNA Chip, Lab-on-a-chip and Protein Chip. By Application, the market is divided into Academics Institutes and Diagnostics Centers. Based on geography, market is analyzed across North America, Europe, Asia-Pacific, Latin America and Middle East and Africa. Major players profiled in the report include Abbott, Agilent, PerkinElmer, Fluidigm, Illumina, GE Healthcare, Bio-Rad Laboratories, Cepheid, Thermo Fisher and Roche.
Key Market Segments
Type
DNA Chip
Lab-on-a-chip
Protein ChipApplication
Academics Institutes
Diagnostics CentersKey Market Players included in the report:
Abbott
Agilent
PerkinElmer
Fluidigm
Illumina
GE Healthcare
Bio-Rad Laboratories
Cepheid
Thermo Fisher
RocheReasons to Get this Report:
In an insight outlook, this research report has dedicated to several quantities of analysis – industry research (global industry trends) and Biochips (Microarrays/Microfluidics) Market share analysis of high players, along with company profiles and which collectively include about the fundamental opinions regarding the market landscape. Emerging and high-growth sections of Biochips (Microarrays/Microfluidics) Market, high-growth regions, and market drivers, restraints and also market chances.
The analysis covers Biochips (Microarrays/Microfluidics) Market and its advancements across different industry verticals as well as regions. It targets estimating the current market size and growth potential of the global Biochips (Microarrays/Microfluidics) Market across sections such as also Application and representatives.
Additionally, the analysis also has a comprehensive review of the crucial players on the Biochips (Microarrays/Microfluidics) Market together side their company profiles, SWOT analysis, latest advancements and business plans.The analysis objectives of the report are:
To equitably share in-depth info regarding the crucial elements impacting the increase of industry (growth capacity, chances, drivers and industry-specific challenges and risks).
To know the Biochips (Microarrays/Microfluidics) Market by pinpointing its many subsegments.
To profile the important players and analyze their growth plans.
To endeavor the amount and value of Biochips (Microarrays/Microfluidics) sub-markets, depending on key regions (various vital states).
To analyze Biochips (Microarrays/Microfluidics) Market concerning growth trends, prospects and also their participation in the entire sector.
To examine and study the Biochips (Microarrays/Microfluidics) Market size (volume & value) from the company, essential regions/countries, products and Application, background information from 2012 to 2018 and also prediction to 2028.
Primary worldwide Biochips (Microarrays/Microfluidics) Market manufacturing companies, to specify, clarify and analyze the product sales amount, value and market share, market rivalry landscape, SWOT analysis and development plans next coming years.
To examine competitive progress such as expansions, arrangements, new product launches and acquisitions on the market. -
Table Of Content
1. Biochips (Microarrays/Microfluidics) Market Introduction
1.1. Definition
1.2. Taxonomy
1.3. Research Scope2. Executive Summary2.1. Key Findings by Major Segments
2.2. Top strategies by Major Players3. Global Biochips (Microarrays/Microfluidics) Market Overview3.1. Biochips (Microarrays/Microfluidics) Market Dynamics
3.1.1. Drivers
3.1.2. Opportunities
3.1.3. Restraints
3.1.4. Challenges3.2. PESTLE Analysis
3.3. Opportunity Map Analysis
3.4. PORTER’S Five Forces Analysis
3.5. Market Competition Scenario Analysis
3.6. Product Life Cycle Analysis
3.7. Opportunity Orbits
3.8. Manufacturer Intensity Map4. Global Biochips (Microarrays/Microfluidics) Market Value (US$ Mn), Share (%), and Growth Rate (%) Comparison by Type, 2012-20284.1. Global Biochips (Microarrays/Microfluidics) Market Analysis by Type: Introduction
4.2. Market Size and Forecast by Region
4.3. DNA Chip
4.4. Lab-on-a-chip
4.5. Protein Chip5. Global Biochips (Microarrays/Microfluidics) Market Value (US$ Mn), Share (%), and Growth Rate (%) Comparison by Application, 2012-20285.1. Global Biochips (Microarrays/Microfluidics) Market Analysis by Application: Introduction
5.2. Market Size and Forecast by Region
5.3. Academics Institutes
5.4. Diagnostics Centers6. Global Biochips (Microarrays/Microfluidics) Market Value (US$ Mn), Share (%), and Growth Rate (%) Comparison by Region, 2012-20286.1. North America
6.1.1. North America Biochips (Microarrays/Microfluidics) Market: Regional Trend Analysis
6.1.1.1. US
6.1.1.2. Canada
6.1.1.3. Mexico6.2. Europe
6.2.1. Europe Biochips (Microarrays/Microfluidics) Market: Regional Trend Analysis
6.2.1.1. Germany
6.2.1.2. France
6.2.1.3. UK
6.2.1.4. Russia
6.2.1.5. Italy
6.2.1.6. Rest of Europe6.3. Asia-Pacific
6.3.1. Asia-Pacific Biochips (Microarrays/Microfluidics) Market: Regional Trend Analysis
6.3.1.1. China
6.3.1.2. Japan
6.3.1.3. Korea
6.3.1.4. India
6.3.1.5. Rest of Asia6.4. Latin America
6.4.1. Latin America Biochips (Microarrays/Microfluidics) Market: Regional Trend Analysis
6.4.1.1. Brazil
6.4.1.2. Argentina
6.4.1.3. Rest of Latin America6.5. Middle East and Africa
6.5.1. Middle East and Africa Biochips (Microarrays/Microfluidics) Market: Regional Trend Analysis
6.5.1.1. GCC
6.5.1.2. South Africa
6.5.1.3. Israel
6.5.1.4. Rest of MEA
7. Global Biochips (Microarrays/Microfluidics) Market Competitive Landscape, Market Share Analysis, and Company Profiles7.1. Market Share Analysis
7.2. Company Profiles
7.3. Abbott7.3.1. Company Overview
7.3.2. Financial Highlights
7.3.3. Product Portfolio
7.3.4. SWOT Analysis
7.3.5. Key Strategies and Developments7.4. Agilent7.4.1. Company Overview
7.4.2. Financial Highlights
7.4.3. Product Portfolio
7.4.4. SWOT Analysis
7.4.5. Key Strategies and Developments7.5. PerkinElmer7.5.1. Company Overview
7.5.2. Financial Highlights
7.5.3. Product Portfolio
7.5.4. SWOT Analysis
7.5.5. Key Strategies and Developments7.6. Fluidigm7.6.1. Company Overview
7.6.2. Financial Highlights
7.6.3. Product Portfolio
7.6.4. SWOT Analysis
7.6.5. Key Strategies and Developments7.7. Illumina7.7.1. Company Overview
7.7.2. Financial Highlights
7.7.3. Product Portfolio
7.7.4. SWOT Analysis
7.7.5. Key Strategies and Developments7.8. GE Healthcare7.8.1. Company Overview
7.8.2. Financial Highlights
7.8.3. Product Portfolio
7.8.4. SWOT Analysis
7.8.5. Key Strategies and Developments7.9. Bio-Rad Laboratories7.9.1. Company Overview
7.9.2. Financial Highlights
7.9.3. Product Portfolio
7.9.4. SWOT Analysis
7.9.5. Key Strategies and Developments7.10. Cepheid7.10.1. Company Overview
7.10.2. Financial Highlights
7.10.3. Product Portfolio
7.10.4. SWOT Analysis
7.10.5. Key Strategies and Developments7.11. Thermo Fisher7.11.1. Company Overview
7.11.2. Financial Highlights
7.11.3. Product Portfolio
7.11.4. SWOT Analysis
7.11.5. Key Strategies and Developments7.12. Roche7.12.1. Company Overview
7.12.2. Financial Highlights
7.12.3. Product Portfolio
7.12.4. SWOT Analysis
7.12.5. Key Strategies and Developments8. Assumptions and Acronyms
9. Research Methodology
10. Contact -
Inquiry Before Buying
-
Request Sample